133 related articles for article (PubMed ID: 2576192)
1. Evaluation of the antifibrillatory activity of fluorinated derivatives of indenolol and nadolol in isolated rabbit and rat hearts: comparison with propranolol.
Almotrefi AA; Aboul-Enein HY; Premkumar LS
Arch Int Pharmacodyn Ther; 1989; 301():122-30. PubMed ID: 2576192
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological evaluation of the antifibrillatory effect of fluorinated derivatives of carazolol and celiprolol: comparison with propranolol.
Almotrefi AA; Dzimiri N; Aboul-Enein HY; Premkumar LS
Gen Pharmacol; 1993 May; 24(3):721-5. PubMed ID: 8103496
[TBL] [Abstract][Full Text] [Related]
3. Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
Patterson E; Lucchesi BR
Pharmacology; 1984; 28(3):121-9. PubMed ID: 6144114
[TBL] [Abstract][Full Text] [Related]
4. Effects of prolonged administration of indenolol in hypertensive rats.
Kato H; Kurihara J; Takata Y; Kunugi H; Miyajima Y
Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):82-95. PubMed ID: 6138007
[TBL] [Abstract][Full Text] [Related]
5. Antifibrillatory actions of nadolol.
Patterson E; Lucchesi BR
J Pharmacol Exp Ther; 1982 Oct; 223(1):144-52. PubMed ID: 6126580
[No Abstract] [Full Text] [Related]
6. Effects of beta-adrenoceptor blockers on mitochondrial ATPase activity in guinea pig heart preparations.
Almotrefi AA; Dzimiri N
Eur J Pharmacol; 1992 May; 215(2-3):231-6. PubMed ID: 1356792
[TBL] [Abstract][Full Text] [Related]
7. Acute effect of indenolol on systemic arterial pressure and heart rate in the rat.
Zuccari G; Falcone A; Turba C
Pharmacol Res Commun; 1986 Feb; 18(2):137-47. PubMed ID: 2871567
[TBL] [Abstract][Full Text] [Related]
8. Some central effects of indenolol in experimental animals.
Tariq M; Babhair SA; Ageel AM; Ginawi OT; Parmar NS
Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):201-9. PubMed ID: 2878478
[TBL] [Abstract][Full Text] [Related]
9. Effects of indenolol (YB-2), a new beta-adrenergic blocking agent, and its dextro isomer on the central nervous system of mice and rabbits.
Tachikawa S; Takenaka T; Maeno H
Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):74-87. PubMed ID: 30422
[TBL] [Abstract][Full Text] [Related]
10. Dose-response studies of indenolol, a beta adrenoceptor blocker.
Okupa FE; Daneshmend TK; Shrosbree E; Roberts CJ
Clin Pharmacol Ther; 1981 Apr; 29(4):434-9. PubMed ID: 6110504
[TBL] [Abstract][Full Text] [Related]
11. Direct and beta adrenergic blocking actions of nadolol (SQ 11725) on electrophysiologic properties of isolated canine myocardium.
Gibson JK; Gelband H; Bassett AL
J Pharmacol Exp Ther; 1977 Sep; 202(3):702-10. PubMed ID: 19621
[TBL] [Abstract][Full Text] [Related]
12. Estimation of cardiodepressant potency of nadolol, alprenolol, propranolol and pindolol, beta-blocking agents, in heart-lung preparation and blood-perfused excised papillary muscle preparation of the dog.
Ono H; Kanazawa Y; O'Hara N; Hashimoto K
Jpn J Pharmacol; 1984 Dec; 36(4):507-17. PubMed ID: 6151997
[TBL] [Abstract][Full Text] [Related]
13. Acute effect of indenolol on human airways.
Zanon P; Bruschi C; Cerveri I; Rossi A; Karitinos P; Pamparana F
Eur J Clin Pharmacol; 1985; 29(3):287-92. PubMed ID: 2866966
[TBL] [Abstract][Full Text] [Related]
14. Anti-arrhythmic action of nadolol, a beta-adrenergic receptor blocking agent.
Evans DB; Peschka MT; Lee RJ; Laffan RJ
Eur J Pharmacol; 1976 Jan; 35(1):17-27. PubMed ID: 3420
[TBL] [Abstract][Full Text] [Related]
15. Indenolol, a beta-blocker with partial agonism at vascular beta-adrenoceptors.
Taddei S; Pedrinelli R; Salvetti A
Clin Pharmacol Ther; 1989 Nov; 46(5):560-5. PubMed ID: 2573443
[TBL] [Abstract][Full Text] [Related]
16. Effects of equiblocking doses of nadolol and propranolol on left ventricular performance.
Le Winter MM; Curtis GP; Engler RL; Shabetai R; Verba J
Clin Pharmacol Ther; 1979 Aug; 26(2):162-6. PubMed ID: 37012
[TBL] [Abstract][Full Text] [Related]
17. The antagonist and partial beta agonist properties of celiprolol in isolated rat cardiac tissue.
Smith RD; Cobuzzi A; Wolf PS; Pruss TP
Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):147-61. PubMed ID: 2870551
[TBL] [Abstract][Full Text] [Related]
18. Effects of beta-adrenergic blockers on Na(+)-K(+)-ATPase activity in guinea-pig heart preparations: comparison with ouabain.
Almotrefi AA; Dzimiri N
Arch Int Pharmacodyn Ther; 1991; 310():94-101. PubMed ID: 1685314
[TBL] [Abstract][Full Text] [Related]
19. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
Matsubara I; Hashimoto K; Katano Y; Tsukada T; Matsuda H
Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of propranolol and nadolol on renal blood flow in normal rats and rats with congestive heart failure.
Brenner BM; Duchin KL; Ichikawa I; Pfeffer J; Pfeffer M
Am Heart J; 1984 Oct; 108(4 Pt 2):1144-7. PubMed ID: 6148876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
